| 000 | 01685 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515005331.0 | ||
| 264 | 0 | _c20060705 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s00280-005-0135-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorton, Terzah M | |
| 245 | 0 | 0 |
_aBortezomib interactions with chemotherapy agents in acute leukemia in vitro. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJul 2006 |
||
| 300 |
_a13-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aHeat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aGannavarapu, Anurhadha | |
| 700 | 1 | _aBlaney, Susan M | |
| 700 | 1 | _aD'Argenio, David Z | |
| 700 | 1 | _aPlon, Sharon E | |
| 700 | 1 | _aBerg, Stacey L | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 58 _gno. 1 _gp. 13-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-005-0135-z _zAvailable from publisher's website |
| 999 |
_c15916550 _d15916550 |
||